menu
    • menu

    Company profile for Compugen

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Compugen is a drug discovery company with a unique, broadly applicable, predictive discovery infrastructure, which is advancing a therapeutic pipeline consisting mainly of early-stage immuno-oncology programs, aimed at harnessing the immune system to eradicate cancer. Our pipeline is based on novel Compugen-discovered drug targets, primarily immune checkpoint candidates that are predicted to provide cancer immunotherapies addr...
    Compugen is a drug discovery company with a unique, broadly applicable, predictive discovery infrastructure, which is advancing a therapeutic pipeline consisting mainly of early-stage immuno-oncology programs, aimed at harnessing the immune system to eradicate cancer. Our pipeline is based on novel Compugen-discovered drug targets, primarily immune checkpoint candidates that are predicted to provide cancer immunotherapies addressing unmet cancer types and patient populations, both as monotherapy and in combination.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CompugenIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Azrieli Center, 26 Harokmim St. Bldg D Holon 5885849, Israel
    Telephone
    Telephone
    +972-3-765-8585
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cgen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Compugen Reports Third Quarter 2025 Results
    Compugen Reports Third Quarter 2025 Results

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/compugen-reports-third-quarter-2025-results-302610022.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Compugen To Participate In Stifel 2025 Healthcare Conference
    Compugen To Participate In Stifel 2025 Healthcare Conference

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/compugen-to-participate-in-stifel-2025-healthcare-conference-302603899.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Compugen To Report Q3 2025 Results On November 10
    Compugen To Report Q3 2025 Results On November 10

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/compugen-to-release-third-quarter-2025-results-on-monday-november-10-2025-302595196.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share
    Compugen to Share COM701 Ph1 Ovarian Cancer Data at ESMO
    Compugen to Share COM701 Ph1 Ovarian Cancer Data at ESMO

    13 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/compugen-to-present-pooled-analysis-of-com701-in-three-phase-1-trials-in-patients-with-platinum-resistant-ovarian-cancer-at-esmo-2025-302581918.html

    PR NEWSWIRE
    13 Oct 2025
    Share Share
    Compugen To Present At SITC 2025
    Compugen To Present At SITC 2025

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/compugen-to-present-at-sitc-2025-302575665.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share
    Compugen to Share Research at Single Cell Genomics 2025 Event
    Compugen to Share Research at Single Cell Genomics 2025 Event

    08 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/compugen-to-present-research-at-the-single-cell-genomics-2025-conference-302548838.html

    PR NEWSWIRE
    08 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search